1-propanol has been researched along with Hypercholesterolemia in 44 studies
1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In view of this, we have evaluated the lipid-lowering effect of a nutraceutical pill containing berberine (BBR) and of ezetimibe, as alternative treatments, in monotherapy or in combination, in 228 subjects with primary hypercholesterolemia (HCH), with history of STs intolerance or refusing STs treatment." | 9.16 | Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. ( Bellocchio, A; Bertolini, S; Pisciotta, L, 2012) |
| "This randomized, double-blind study was undertaken to compare the efficacy and tolerability of policosanol (10 mg/day) and lovastatin (20 mg/day) in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus." | 9.09 | Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. ( Castaño, G; Crespo, N; Fernández, J; Fernández, L; Illnait, J; Más, R, 1999) |
| " In view of this, we have evaluated the lipid-lowering effect of a nutraceutical pill containing berberine (BBR) and of ezetimibe, as alternative treatments, in monotherapy or in combination, in 228 subjects with primary hypercholesterolemia (HCH), with history of STs intolerance or refusing STs treatment." | 5.16 | Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. ( Bellocchio, A; Bertolini, S; Pisciotta, L, 2012) |
| " We evaluated the effects of a nutraceutical combination (NC), consisting of 500 mg berberine, 200mg red yeast rice and 10mg policosanols, on cholesterol levels and endothelial function in patients with hypercholesterolemia." | 5.14 | Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. ( Affuso, F; Fazio, S; Micillo, F; Ruvolo, A; Saccà, L, 2010) |
| "This randomized, double-blind study was undertaken to compare the effects of policosanol and pravastatin administered at 10 mg/day on lipid profile, platelet aggregation and endothelemia in older patients with type II hypercholesterolemia and high coronary risk." | 5.09 | Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. ( Arruzazabala, ML; Castaño, G; Fernández, JC; Illnait, J; Más, R; Menéndez, A; Molina, V; Noa, M, 1999) |
| "This randomized, double-blind study was undertaken to compare the efficacy and tolerability of policosanol (10 mg/day) and lovastatin (20 mg/day) in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus." | 5.09 | Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. ( Castaño, G; Crespo, N; Fernández, J; Fernández, L; Illnait, J; Más, R, 1999) |
| " These results could explain the variability observed in the response to berberine among people with moderate hypercholesterolemia, and they may be useful in identifying patients who could potentially benefit from supplementation with AP." | 3.83 | Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine. ( Brea, A; De Castro-Orós, I; Mozas, P; Pocoví, M; Puzo, J; Solà, R; Valls, RM, 2016) |
| " The highest post-treatment changes were seen after GM combination with CP (CholT 85 ± 3% and LDL 85 ± 5%, of pretreatment) which was significantly (p < 0." | 2.78 | Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan. ( Barillà, F; Colantoni, C; Martino, E; Martino, F; Niglio, T; Pannarale, G; Puddu, PE; Zanoni, C, 2013) |
| " No adverse effects were detected when liver and muscular enzymes (AST, ALT, and CK) were determined." | 2.76 | The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. ( Abello, F; Baracco, V; Guardamagna, O; Martino, F; Stasiowska, B, 2011) |
| "The use of policosanol to treat elevated cholesterol is based on clinical trials conducted in Cuba, which showed sugar cane-derived policosanol to be similar in efficacy to statins." | 2.72 | Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. ( Barringer, TA; Dulin, MF; Hatcher, LF; Sasser, HC, 2006) |
| " Both treatments were safe and well tolerated." | 2.70 | Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia. ( Alvarez, E; Castaño, G; Fernández, J; Fernández, L; Illnait, J; Lezcay, M; Mas, R; Mesa, M, 2002) |
| " However, policosanol, a mixture of long-chain aliphatic alcohols extractable from sugar cane wax, has shown cholesterol-lowering potency comparable to that of statins, and yet appears to be devoid of toxic risk." | 1.31 | Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. ( McCarty, MF, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.55) | 18.7374 |
| 1990's | 5 (11.36) | 18.2507 |
| 2000's | 24 (54.55) | 29.6817 |
| 2010's | 13 (29.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nam, DE | 1 |
| Yun, JM | 1 |
| Kim, D | 1 |
| Kim, OK | 1 |
| Martino, F | 2 |
| Puddu, PE | 1 |
| Pannarale, G | 1 |
| Colantoni, C | 1 |
| Martino, E | 1 |
| Niglio, T | 1 |
| Zanoni, C | 1 |
| Barillà, F | 1 |
| Barrat, E | 2 |
| Zaïr, Y | 2 |
| Ogier, N | 2 |
| Housez, B | 2 |
| Vergara, C | 1 |
| Maudet, C | 2 |
| Lescuyer, JF | 3 |
| Bard, JM | 2 |
| Carpentier, YA | 1 |
| Cazaubiel, M | 2 |
| Peltier, SL | 3 |
| Mazza, A | 1 |
| Lenti, S | 1 |
| Schiavon, L | 1 |
| Zuin, M | 1 |
| D'Avino, M | 1 |
| Ramazzina, E | 1 |
| Casiglia, E | 1 |
| De Castro-Orós, I | 1 |
| Solà, R | 1 |
| Valls, RM | 1 |
| Brea, A | 1 |
| Mozas, P | 1 |
| Puzo, J | 1 |
| Pocoví, M | 1 |
| Sanchez, J | 1 |
| Illnait, J | 9 |
| Mas, R | 10 |
| Mendoza, S | 2 |
| Fernandez, L | 7 |
| Mesa, M | 3 |
| Vega, H | 1 |
| Fernandez, J | 5 |
| Reyes, P | 1 |
| Ruiz, D | 1 |
| Francini-Pesenti, F | 2 |
| Brocadello, F | 2 |
| Beltramolli, D | 2 |
| Nardi, M | 1 |
| Caregaro, L | 1 |
| Murphy, KJ | 1 |
| Saint, DA | 1 |
| Howe, PR | 1 |
| Jargin, SV | 1 |
| Kassis, AN | 4 |
| Kubow, S | 1 |
| Jones, PJ | 4 |
| Affuso, F | 1 |
| Ruvolo, A | 1 |
| Micillo, F | 1 |
| Saccà, L | 1 |
| Fazio, S | 1 |
| Guardamagna, O | 1 |
| Abello, F | 1 |
| Baracco, V | 1 |
| Stasiowska, B | 1 |
| Marinangeli, CP | 2 |
| Eskin, MN | 1 |
| Marazzi, G | 1 |
| Cacciotti, L | 1 |
| Pelliccia, F | 1 |
| Iaia, L | 1 |
| Volterrani, M | 1 |
| Caminiti, G | 1 |
| Sposato, B | 1 |
| Massaro, R | 1 |
| Grieco, F | 1 |
| Rosano, G | 1 |
| Amiot, MJ | 1 |
| Georgé, S | 1 |
| Maillot, M | 1 |
| Mallmann, C | 1 |
| Maraninchi, M | 1 |
| Morange, S | 1 |
| Cardinault, N | 1 |
| Pisciotta, L | 1 |
| Bellocchio, A | 1 |
| Bertolini, S | 1 |
| Sirvent, P | 1 |
| Chauveau, P | 1 |
| Derbord, E | 1 |
| Janikula, M | 1 |
| McCarty, MF | 1 |
| Castaño, G | 6 |
| Alvarez, E | 2 |
| Lezcay, M | 1 |
| Lin, Y | 1 |
| Rudrum, M | 1 |
| van der Wielen, RP | 1 |
| Trautwein, EA | 1 |
| McNeill, G | 1 |
| Sierksma, A | 1 |
| Meijer, GW | 1 |
| Gámez, R | 1 |
| Gutiérrez, JA | 1 |
| López, E | 1 |
| Greyling, A | 1 |
| De Witt, C | 1 |
| Oosthuizen, W | 1 |
| Jerling, JC | 1 |
| Berthold, HK | 2 |
| Unverdorben, S | 1 |
| Degenhardt, R | 1 |
| Bulitta, M | 1 |
| Gouni-Berthold, I | 2 |
| Cubeddu, LX | 1 |
| Cubeddu, RJ | 1 |
| Heimowitz, T | 1 |
| Restrepo, B | 1 |
| Lamas, GA | 1 |
| Weinberg, GB | 1 |
| Jain, D | 1 |
| Ebine, N | 1 |
| Dulin, MF | 1 |
| Hatcher, LF | 1 |
| Sasser, HC | 1 |
| Barringer, TA | 1 |
| Dall'acqua, S | 1 |
| Reiner, Z | 1 |
| Tedeschi-Reiner, E | 1 |
| Torres, O | 1 |
| Agramonte, AJ | 1 |
| Más Ferreiro, R | 1 |
| Fernández, JC | 3 |
| Menéndez, R | 2 |
| Arruzazabala, L | 1 |
| Del Río, A | 1 |
| Amor, AM | 1 |
| González, RM | 1 |
| Carbajal, D | 2 |
| Fraga, V | 1 |
| Molina, V | 3 |
| Alemán, C | 1 |
| Pontigas, V | 1 |
| Lescay, M | 1 |
| Arruzazabala, ML | 2 |
| Noa, M | 2 |
| Valdés, S | 1 |
| Menéndez, A | 1 |
| Crespo, N | 1 |
| Mirkin, A | 1 |
| Martinto, M | 1 |
| Boccanera, R | 1 |
| Robertis, A | 1 |
| Poudes, R | 1 |
| Fuster, A | 1 |
| Lastreto, E | 1 |
| Yañez, M | 1 |
| Irico, G | 1 |
| McCook, B | 1 |
| Farré, A | 1 |
| Hofrichter, G | 1 |
| Hampel, H | 1 |
| Liehn, HD | 1 |
| Ludwig, E | 1 |
| Bowyer, RC | 1 |
| Curnow, DH | 1 |
| Stenhouse, NS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Policosanol on Elderly Patients With Endothelial Dysfunction[NCT02543099] | Phase 3 | 100 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
| Effect of a Nutraceutical Combination on Endothelial Injury and C-reactive Protein in Patients With Low-grade Systemic Inflammation[NCT02422927] | Phase 4 | 100 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
| The Study of Berberine Affecting Metabolism, Inflammation Status, Endothelial Function and Thrombotic Events in Patients With Coronary Artery Disease by Remodeling Gut Microbiota[NCT04434365] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2019-06-21 | Active, not recruiting | ||
| Effect of a Nutraceutical, Containing Red Yeast Rice and Polycosanols (Armolipid), on Lipid Profile in Children With Moderate and Severe Hypercholesterolemia.[NCT06045377] | 90 participants (Actual) | Interventional | 2020-01-20 | Completed | |||
| Dose Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia[NCT01354340] | 45 participants (Actual) | Interventional | 2011-04-30 | Completed | |||
| Placebo-Controlled, Randomised, Double-Blind, Multi-Centre Clinical Trial on Dose-Dependent Cholesterol-Lowering Effects of Policosanol in Patients With Hypercholesterolaemia With 10 to 80 Mg Policosanol for 12 Weeks[NCT00288483] | Phase 3 | 0 participants | Interventional | 2000-09-30 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for 1-propanol and Hypercholesterolemia
| Article | Year |
|---|---|
Policosanols as nutraceuticals: fact or fiction.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; | 2010 |
Policosanol: a new treatment for cardiovascular disease?
Topics: Anticholesteremic Agents; Cardiovascular System; Cholesterol, HDL; Cholesterol, LDL; Cuba; Diabetes | 2002 |
Monograph. Policosanol.
Topics: Anticholesteremic Agents; Fatty Alcohols; Humans; Hypercholesterolemia; Intermittent Claudication; M | 2004 |
Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
Topics: Anticholesteremic Agents; Cholesterol; Drug Interactions; Fatty Alcohols; Humans; Hypercholesterolem | 2002 |
28 trials available for 1-propanol and Hypercholesterolemia
| Article | Year |
|---|---|
Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan.
Topics: Adolescent; Atherosclerosis; Blood Glucose; Cathartics; Child; Child, Preschool; Cholesterol, HDL; C | 2013 |
A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.
Topics: Adult; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein B-100; Biological Products; Chol | 2013 |
Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
Topics: Berberine; Biological Products; Blood Pressure; Cardiovascular Diseases; Diet; Dietary Supplements; | 2015 |
[Long-term effect of policosanol on the functional recovery of non-cardioembolic ischemic stroke patients: a one year study].
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aspirin; Brain Damage, Chronic; Brain Ischemia; C | 2017 |
Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study.
Topics: Anticholesteremic Agents; Body Mass Index; Body Weight; Cholesterol; Complementary Therapies; Diet; | 2008 |
Sugar cane policosanols do not reduce LDL oxidation in hypercholesterolemic individuals.
Topics: Anticholesteremic Agents; Body Weight; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; En | 2009 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Sup | 2010 |
The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols.
Topics: Adolescent; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Biological Products; Ch | 2011 |
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Berberine; Biological Products; Blood Glucose; Ch | 2011 |
LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Ascorbic Acid; Biological Products; Cholesterol, HDL; Cholesterol, | 2013 |
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.
Topics: Aged; Anticholesteremic Agents; Azetidines; Berberine; Biological Products; Cholesterol, LDL; Dietar | 2012 |
Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Animals; Anticholesteremic Agents; Biological Products; Biomarkers; Cholest | 2013 |
Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
Topics: Adult; Aged; Alcohols; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypercholesterolemia; Ma | 2002 |
Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Bilirubin; Cholesterol; Diet; Dietary Fats; Doubl | 2004 |
Concomitant use of policosanol and beta-blockers in older patients.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Coronary Dise | 2004 |
Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cross-Over Studies; Dietary Su | 2006 |
Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Topics: Adult; Aged; Anticholesteremic Agents; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypercho | 2006 |
Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Drug Therapy, | 2006 |
Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol | 2006 |
Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.
Topics: Adult; Anticholesteremic Agents; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL | 2006 |
Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
Topics: Anticholesteremic Agents; Body Mass Index; Cholesterol; Double-Blind Method; Fatty Alcohols; Female; | 2008 |
Rice policosanol does not have any effects on blood coagulation factors in hypercholesterolemic patients.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Coagulation Factors; Cross-Over Studies; Double-Blind M | 2007 |
Treatment of hypercholesterolemia in NIDDM with policosanol.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Dia | 1995 |
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
Topics: Aged; Anticholesteremic Agents; Coronary Disease; Double-Blind Method; Fatty Alcohols; Female; Human | 1999 |
Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Double-Blind Method; Endothelium, Vascular; Fatty | 1999 |
Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
Topics: Anticholesteremic Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Alco | 1999 |
Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
Topics: Aged; Anticholesteremic Agents; Cardiovascular System; Cholesterol; Cholesterol, HDL; Cholesterol, L | 2001 |
Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fatt | 2001 |
12 other studies available for 1-propanol and Hypercholesterolemia
| Article | Year |
|---|---|
Policosanol Attenuates Cholesterol Synthesis via AMPK Activation in Hypercholesterolemic Rats.
Topics: AMP-Activated Protein Kinases; Animals; Anticholesteremic Agents; Aorta; Apolipoprotein B-100; Chole | 2019 |
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
Topics: Adult; Aged; Alleles; Berberine; Cholesterol, LDL; Fatty Alcohols; Female; Heterozygote; Humans; Hyp | 2016 |
Lack of effect of sugar cane and sunflower seed policosanols on plasma cholesterol in rabbits.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Fatty Alcohols; Female; Hypercholesterolemia; Lipids | 2008 |
Discussion of Evaluation of cholesterol-lowering and antioxidant properties of sugar cane policosanols in hamsters and humans.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Cricetinae; Fatty Alcohols; Humans; Hy | 2009 |
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
Topics: Animals; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Diet, Vegetarian; Dietary Fats; | 2002 |
A close look at coenzyme Q10 and policosanol. Do these supplements live up to their claims for improving heart health?
Topics: Anticholesteremic Agents; Attitude to Health; Cardiovascular Diseases; Coenzymes; Fatty Alcohols; He | 2002 |
Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters.
Topics: Animal Feed; Animals; Anticholesteremic Agents; Body Weight; Cholesterol, Dietary; Cholesterol, HDL; | 2007 |
Policosanol: a sweet nothing for high cholesterol.
Topics: Anticholesteremic Agents; Fatty Alcohols; Humans; Hypercholesterolemia; Treatment Failure | 2006 |
Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.
Topics: Animals; Anticholesteremic Agents; Caseins; Cholesterol; Cholesterol, LDL; Fatty Alcohols; Hyperchol | 1997 |
Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Aortic Diseases; Arteriosclerosis; Case-Con | 2000 |
[Pharmacologic evaluation of 3-butoxy-l-phenoxy-propanol-(2), a new substance with choleretic activity].
Topics: 1-Propanol; Animals; Anticonvulsants; Bile; Bile Acids and Salts; Body Weight; Cats; Cholagogues and | 1974 |
The second Busselton adult population survey (1969): serum cholesterol.
Topics: 1-Propanol; Adult; Age Factors; Aged; Australia; Cholesterol; Diabetes Mellitus; Feedback; Female; H | 1974 |